InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Atlas Venture Fund XII, L.P.. Insider active across 2 companies, notably Aerovate Therapeutics, Inc.. In total, 6 disclosures have been published. Activity tracked since 1 April 2022. The latest transaction was filed on 15 July 2022 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
310,388 shares0Common StockSEC:0001209191-22-042614:0
465,582 shares0Common StockSEC:0001209191-22-022540:0
2,831,520 sharesCommon StockSEC:0000899243-22-001654
2,831,520 sharesCommon StockSEC:0000899243-22-001654:0
2,568,165 sharesCommon StockSEC:0001104659-21-089434
2,568,165 sharesCommon StockSEC:0001104659-21-089434:0
6 of 6 declarations
About Atlas Venture Fund XII, L.P.
Atlas Venture Fund XII, L.P. is a director and insider, primarily involved with Aerovate Therapeutics, Inc. and Vigil Neuroscience, Inc.
